Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ERIS LIFESCIENCES Gains 5%; BSE HEALTHCARE Index Up 0.5%
Thu, 29 Aug 9:33

ERIS LIFESCIENCES Gains 5%; BSE HEALTHCARE Index Up 0.5%Image source: StarLineArts/www.istockphoto.com

ERIS LIFESCIENCES share price has zoomed 5% and is presently trading at Rs 1,366.5.

Meanwhile, the BSE HEALTHCARE index is at 42,943.0 (up 0.5%).

Among the top gainers in the BSE HEALTHCARE index today are SUVEN PHARMACEUTICALS (up 1.2%) and Biocon (up 1.1%).

Procter & Gamble Health (down 1.2%) and ALEMBIC PHARMA (down 0.8%) are among the top losers today.

Over the last one year, ERIS LIFESCIENCES has moved up from Rs 800.3 to Rs 1,366.5, registering a gain of Rs 566.3 (up 70.8%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,859.6 to 42,943.0, registering a gain of 54.1% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were GRANULES INDIA (up 136.4%), Glenmark Pharma (up 122.7%) and SUVEN PHARMACEUTICALS (up 108.2%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 81,826.9 (up 0.1%).

The top gainers among the BSE Sensex today are Sun Pharma (up 0.6%) and Hindustan Unilever (up 0.5%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 25,054.3 . Cipla and Bajaj Auto are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 64,996.6 to 81,826.9, registering a gain of 16,830.3 points (up 25.9%).

ERIS LIFESCIENCES Financial Update...

ERIS LIFESCIENCES net profit fell 4.5% YoY to Rs 894 million for the quarter ended June 2024, compared to a profit of Rs 937 million a year ago. Net sales rose 54.2% to Rs 7,197 million during the period as against Rs 4,666 million in April-June 2023.

For the year ended March 2023, ERIS LIFESCIENCES reported 7.8% decrease in net profit to Rs 3,742 million compared to net profit of Rs 4,058 million during FY22. Revenue of the company grew 25.1% to Rs 16,851 million during FY23.

The current Price to earnings ratio of ERIS LIFESCIENCES, based on rolling 12 month earnings, stands at 47.3.


Equitymaster requests your view! Post a comment on "ERIS LIFESCIENCES Gains 5%; BSE HEALTHCARE Index Up 0.5%". Click here!